What is Stembanc?
Founded in 2002, Stembanc, Inc. operates at the intersection of biotechnology and family healthcare, specializing in the collection, processing, and long-term cryopreservation of newborn umbilical cord blood and tissue stem cells. The company maintains a state-of-the-art laboratory facility strategically situated near leading medical research institutions, ensuring high-fidelity storage protocols. By providing families with accessible and reliable stem cell banking services, Stembanc facilitates the preservation of biological assets that hold significant potential for future therapeutic applications in treating a variety of complex health conditions.
How much funding has Stembanc raised?
Stembanc has raised a total of $57K across 1 funding round:
Debt
$57K
Debt (2021): $57K with participation from PPP
Key Investors in Stembanc
PPP
Public-Private Partnership
What's next for Stembanc?
The recent influx of capital is expected to catalyze a phase of aggressive scaling for Stembanc. As the company transitions through its current growth stage, management is likely to prioritize the expansion of its laboratory capacity and the optimization of its logistics network for stem cell collection. Furthermore, the firm is well-positioned to invest in research and development initiatives that could broaden its service offerings. By strengthening its market position, Stembanc aims to solidify its reputation as a leader in the cryopreservation industry, ensuring that its infrastructure remains aligned with the evolving standards of modern regenerative medicine and clinical research requirements.
See full Stembanc company page
